医学
列线图
前瞻性队列研究
肺癌筛查
危险系数
入射(几何)
内科学
肺癌
食管癌
螺旋CT
队列
人口
癌症
肿瘤科
外科
计算机断层摄影术
置信区间
物理
光学
环境卫生
作者
Haifan Xiao,Zhaohui Shi,Yan‐Hua Zou,Kekui Xu,Xiaoping Yu,Lu Wen,Yang Liu,Haiyan Chen,Huajun Long,Jihuai Chen,Yanling Liu,Shiyu Cao,Can Li,Yingyun Hu,Xianzhen Liao,Shipeng Yan
出处
期刊:Lung Cancer
[Elsevier BV]
日期:2023-01-07
卷期号:177: 1-10
被引量:9
标识
DOI:10.1016/j.lungcan.2023.01.005
摘要
BACKGROUND: To improve the early stage diagnosis and reduce the lung cancer (LC) mortality for positive nodule (PN) population, data on effectiveness of PN detection using one-off low-dose spiral computed tomography (LDCT) screening are needed to improve the PN management protocol. We evaluate the effectiveness of PN detection and developed a nomogram to predict LC risk for PNs. METHODS: A prospective, community-based cohort study was conducted. We recruited 292,531 eligible candidates during 2012-2018. Individuals at high risk of LC based on risk assessment underwent LDCT screening and were divided into PN and non-PN groups. The effectiveness of PN detection was evaluated in LC incidence, mortality, and all-cause mortality. We performed subgroup analysis of characteristic variables for the association between PN and LC risk. A competing risk model was used to develop the nomogram. RESULTS: Participants (n = 14901) underwent LDCT screening; PNs were detected in 1193 cases (8·0%). After a median follow-up of 6·1 years, 193 were diagnosed with LC (1·3%). Of these, 94 were in the PN group (8·0%). LC incidence, mortality, and all-cause mortality were significantly higher in the PN group (adjusted hazard ratios: 10.60 (7.91-14.20), 7.97 (5.20-12.20), and 1.94 (1.51-2.50), respectively). Additionally, various PN characteristics were associated with an increased probability of developing LC. The C-index value of the nomogram for predicting LC risk of PN individuals was 0·847. CONCLUSIONS: The protocol of PNs management for improvement could focus on specific characteristic population and high-risk PN individuals by nomogram assessment.
科研通智能强力驱动
Strongly Powered by AbleSci AI